Expect Pfizer/BioNTech and Moderna Coronavirus Vaccine Data Readouts in November-December, U.S. Vaccine Program Head Says
The head of the U.S. government's Operation Warp Speed COVID-19 vaccine program, Moncef Slaoui, said he expects phase 3 clinical trial data for multiple coronavirus vaccines in the November-to-December timeframe. BNT162b2, the vaccine developed by Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) and mRNA-1273 from Moderna (NASDAQ: MRNA) will be in the first round Slaoui said at a symposium conducted by the Johns Hopkins University and the University of Washington. Data on AstraZeneca's (NYSE: AZN) vaccine from studies in the U.K., Brazil, and South Africa could come in late October to November.
That's a slight delay from the projections the companies have given for the earliest the data could be available. Pfizer and BioNTech have said they could have data as early as the end of this month. And Moderna's management has made reference to having data around Thanksgiving. Of course, depending when in November or December the data appears, the delay could just be a matter of a few days.
Image source: Getty Images.
Source Fool.com
